CAS 1357160-72-5 URB937 - Analytical Products / Alfa Chemistry

CAT	AP1357160725
CAS	1357160-72-5
Molecular Weight	354.40

Description	≥95% (HPLC)
Solubility	DMSO: 15 mg/mL, clear
Assay	≥95% (HPLC)
Color	white to beige
Form	powder (1:1 ratio of product to ethanol)
Size	5MG, 25MG
Storage Conditions	−20°C

1

Brain Permeant and Impermeant Inhibitors of Fatty-Acid Amide Hydrolase Suppress the Development and Maintenance of Paclitaxel-Induced Neuropathic Pain Without Producing Tolerance or Physical Dependence in Vivo and Synergize With Paclitaxel to Reduce Tumor Cell Line Viability in Vitro

Richard A Slivicki, Zhili Xu, Sonali S Mali, Andrea G Hohmann

Pharmacol Res. 2019 Apr;142:267-282.

PMID: 30739035

1

Brain-Permeant and -Impermeant Inhibitors of Fatty Acid Amide Hydrolase Synergize With the Opioid Analgesic Morphine to Suppress Chemotherapy-Induced Neuropathic Nociception Without Enhancing Effects of Morphine on Gastrointestinal Transit

Richard A Slivicki, Shahin A Saberi, Vishakh Iyer, V Kiran Vemuri, Alexandros Makriyannis, Andrea G Hohmann

J Pharmacol Exp Ther. 2018 Dec;367(3):551-563.

PMID: 30275151

1

Inhibition of Fatty Acid Amide Hydrolase Improves Depressive-Like Behaviors Independent of Its Peripheral Antinociceptive Effects in a Rat Model of Neuropathic Pain

Hai-Xia Jiang, Bo-Wen Ke, Jin Liu, Gang Ma, Ke-Rong Hai, De-Ying Gong, Zheng Yang, Cheng Zhou

Anesth Analg. 2019 Aug;129(2):587-597.

PMID: 29863609

1

Suppression of Acute and Anticipatory Nausea by Peripherally Restricted Fatty Acid Amide Hydrolase Inhibitor in Animal Models: Role of PPARα and CB

Erin M Rock, Guillermo Moreno-Sanz, Cheryl L Limebeer, Gavin N Petrie, Roberto Angelini, Daniele Piomelli, Linda A Parker

Br J Pharmacol. 2017 Nov;174(21):3837-3847.

PMID: 28805944

* Products or Services Interested: URB937 (1357160-72-5)
* Your question
* Name
* Email
Verification Code